- Home
- Publications
- Publication Search
- Publication Details
Title
Minireview: Regulatory T Cells and Ovarian Cancer
Authors
Keywords
-
Journal
IMMUNOLOGICAL INVESTIGATIONS
Volume 45, Issue 8, Pages 712-720
Publisher
Informa UK Limited
Online
2016-07-16
DOI
10.1080/08820139.2016.1186689
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer
- (2015) Keith L. Knutson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry
- (2015) Saskia J. A. M. Santegoets et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients
- (2015) Tomáš Brtnický et al. HUMAN IMMUNOLOGY
- Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients
- (2015) I. Wertel et al. TUMOR BIOLOGY
- Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance
- (2015) Izabela Winkler et al. Journal of Ovarian Research
- GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing
- (2015) Miran Jang et al. OncoImmunology
- Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients
- (2014) Johannes Landskron et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- WNT16B from Ovarian Fibroblasts Induces Differentiation of Regulatory T Cells through β-Catenin Signal in Dendritic Cells
- (2014) Cong-Cong Shen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pan-Bcl-2 Inhibitor, GX15-070 (Obatoclax), Decreases Human T Regulatory Lymphocytes while Preserving Effector T Lymphocytes: A Rationale for Its Use in Combination Immunotherapy
- (2014) P. S. Kim et al. JOURNAL OF IMMUNOLOGY
- Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
- (2014) Lei Lu et al. Journal of Translational Medicine
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Analysis of FoxP3+ T-Regulatory Cells and CD8+T-Cells in Ovarian Carcinoma: Location and Tumor Infiltration Patterns Are Key Prognostic Markers
- (2014) Cecilia Hermans et al. PLoS One
- Large-Scale Evaluation of Common Variation in Regulatory T Cell-Related Genes and Ovarian Cancer Outcome
- (2014) B. Charbonneau et al. Cancer Immunology Research
- Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
- (2014) Daniela Luvero et al. Therapeutic Advances in Medical Oncology
- Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities
- (2014) Magdalena Kovacsovics-Bankowski et al. Journal for ImmunoTherapy of Cancer
- Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment
- (2013) Chindu Govindaraj et al. CLINICAL IMMUNOLOGY
- The Immune System in the Pathogenesis of Ovarian Cancer
- (2013) Bridget Charbonneau et al. CRITICAL REVIEWS IN IMMUNOLOGY
- High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer
- (2013) Ryan O Emerson et al. JOURNAL OF PATHOLOGY
- Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer
- (2013) Zhiqiang Guo et al. Journal of Translational Medicine
- A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
- (2013) Lana E Kandalaft et al. Journal of Translational Medicine
- Tim-3 Expression Defines Regulatory T Cells in Human Tumors
- (2013) Jing Yan et al. PLoS One
- The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer
- (2013) Claudia C. Preston et al. PLoS One
- Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment
- (2013) Curdin Conrad et al. OncoImmunology
- CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
- (2012) N. Redjimi et al. CANCER RESEARCH
- Negative Regulation of Myeloid-derived Suppressor Cells in Cancer
- (2012) Peng Qu et al. IMMUNOLOGICAL INVESTIGATIONS
- Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells
- (2012) Anna Fialová et al. INTERNATIONAL JOURNAL OF CANCER
- Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses
- (2012) Yu-Li Chen et al. PLoS One
- Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy
- (2012) Anthony Park et al. Cancers
- Distinct Subpopulations of Epithelial Ovarian Cancer Cells Can Differentially Induce Macrophages and T Regulatory Cells Toward a Pro-Tumor Phenotype
- (2011) Ayesha B. Alvero et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
- (2011) Christina S. Chu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Enhancement of anti-tumor immunity through local modulation of CTLA-4 and GITR by dendritic cells
- (2011) Scott K. Pruitt et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study
- (2011) Renee Vermeij et al. INTERNATIONAL JOURNAL OF CANCER
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Regulatory T Cell as a Target for Cancer Therapy
- (2010) Lucas Cunha Dias de Rezende et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Circulating Regulatory T Cells in Endometrial Cancer: A Role for Age and Menopausal Status
- (2010) Saladin Sawan et al. IMMUNOLOGICAL INVESTIGATIONS
- Low molecular weight fraction secreted by SKOV3 cells expands peripheral CD4+CD25+ regulatory T cells and enhances their suppressive capacity
- (2009) Xiao Li et al. MEDICAL ONCOLOGY
- Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
- (2008) E. Huarte et al. CANCER RESEARCH
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started